Proteome profiling to advance management of metabolic dysfunction-associated fatty liver disease

Hepatobiliary Surg Nutr. 2024 Feb 1;13(1):147-149. doi: 10.21037/hbsn-23-596. Epub 2024 Jan 11.
No abstract available

Keywords: Metabolic dysfunction-associated fatty liver disease (MAFLD); biomarkers; fatty liver disease (FLD); fibrosis; proteome.

Publication types

  • Editorial